Boehler Adam
Known title: DirectorCIK: 0001982325
Boehler Adam's purchase track record
How the stock did after each of Boehler Adam's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since May 21, 2024
Stock higher 6 months later
100%
3 months: 100%
Median 6-month return
+30.7%
3 months: +22.7%
Beat the S&P 500
100%
median +18.2% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/11/2024 | PRVA | $6K | +10.7% | +29.1% | +12.3% |
| 5/29/2024 | PRVA | $88K | +24.7% | +32.1% | +13.9% |
| 5/21/2024 | PRVA | $9.05M | +22.7% | +30.7% | +11.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| PRVA | ▲ Buy | Open Market | 364 | $6K | 6/11/2024 | View on chart |
| PRVA | ▲ Buy | Open Market | 5,306 | $88K | 5/29/2024 | View on chart |
| PRVA | ▲ Buy | Open Market | 4,280 | $71K | 5/24/2024 | View on chart |
| PRVA | ▲ Buy | Open Market | 172,642 | $2.8M | 5/23/2024 | View on chart |
| PRVA | ▲ Buy | Open Market | 102,229 | $1.7M | 5/22/2024 | View on chart |
| PRVA | ▲ Buy | Open Market | 277,565 | $4.5M | 5/21/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Privia Health to Report Q3 2026 Results on Nov 5
Privia Health Group is scheduled to announce its third-quarter 2026 financial results on November 5. Recent coverage highlights the company's role in healthcare automation aimed at reducing administrative costs. With the stock currently trading near its support level, investors will be watching the earnings report for updates on revenue trends and cost management.
Privia Health to Report Q3 2026 Results on Nov 5. Privia Health Group is scheduled to announce its third-quarter 2026 financial results on November 5. Recent coverage highlights the company's role in healthcare automation aimed at reducing administrative costs. With the stock currently trading near its support level, investors will be watching the earnings report for updates on revenue trends and cost management.